跳至主要内容
临床试验/NCT00879164
NCT00879164已完成早期 1 期

Pilot Evaluation of a Stellate Ganglion Block for the Treatment of Hot Flashes

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2009年4月最近更新:
适应症
相关药物

试验速览

阶段
早期 1 期
状态
已完成
发起方
Mayo Clinic
入组人数
10
试验地点
2
主要终点
Difference in hot flash activity between baseline and week 7

研究概览

简要总结

RATIONALE: A stellate ganglion nerve block may help relieve hot flashes in women.

PURPOSE: This clinical trial is studying how well a stellate ganglion nerve block works in treating women with hot flashes.

详细描述

OBJECTIVES:

  • To evaluate the impact of stellate ganglion blockade on hot flash scores.
  • To evaluate the toxicity of stellate ganglion blockade.

OUTLINE: Patients undergo fluoroscopic-guided stellate ganglion blockade using bupivacaine hydrochloride in week 1.

Patients complete a hot flash diary daily and a symptom experience diary weekly in weeks 1-7 and the Profile of Mood States questionnaire in weeks 1 and 7.

After completion of study treatment, patients are followed at 2 months and then monthly for 1 year.

研究设计

研究类型
Interventional
主要目的
Supportive Care

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Difference in hot flash activity between baseline and week 7

次要结局

  • Difference in quality of life, toxicity, and self-assessment items between baseline and week 7

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验